查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494837

感染疾病診斷的全球市場：分析 - 按產品、按疾病、按技術、按最終用戶、按地區、預測（至 2030 年）

Infectious Disease Diagnostics Market Forecasts to 2030 - Global Analysis By Product, Disease, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球感染疾病診斷市場規模預計到2024年將達到236.3億美元，到2030年將達到427.8億美元，預測期內複合年成長率為10.4%。

感染疾病診斷是指識別人體內是否有細菌、病毒、真菌、寄生蟲等病原體，以診斷感染疾病的過程。這些診斷使用各種旨在檢測特定病原體及其標記物的技術和方法，通常透過分析體液、組織或其他樣本。快速診斷測試 (RDT) 也可用於在資源有限的環境中進行快速識別。準確及時診斷感染疾病對於有效的患者管理、開始適當的治療、實施感染控制措施和疾病監測至關重要。

根據美國疾病管制與預防美國(CDC) 的數據，2018 年，美國醫院每年報告約 170 萬人感染疾病和 99,000 人相關死亡。據美國食品藥物管理局（FDA）稱，2020年，每年約有30萬名50歲以上的人被診斷出患有肺炎球菌肺炎。

對就地檢驗的需求不斷成長

就地檢驗提供了一種快速、方便和分散式檢查解決方案，可在患者床邊或社區環境中快速診斷並及時做出治療決策。這種向 POCT 的轉變是由多種因素推動的，包括快速週轉時間的需要，特別是在感染疾病爆發和像 COVID-19 這樣的大流行期間。此外，POCT 減輕了集中檢測設施和醫療基礎設施的負擔，使服務不足的人口和偏遠地區更容易進行檢測。

診斷測試成本高

診斷測試的高成本是感染疾病診斷市場成長的主要障礙。這些成本包括測試開發、製造和分銷等各個方面，所有這些成本都會影響支付給患者和醫療保健系統的最終價格。對於許多患者，尤其是低收入和中等收入國家的患者來說，這些費用令人望而卻步，並導致診斷和後續治療的延遲或漏診。然而，高昂的費用使醫療保健預算緊張，並限制了獲得基本診斷服務的機會。

公眾健康意識不斷增強

公眾健康意識的提高對感染疾病診斷市場的成長做出了重大貢獻。隨著人們對早期發現和預防感染疾病重要性的認知不斷加深，個人和政府正在診斷技術上投入更多資源。像 COVID-19 大流行這樣的全球健康危機凸顯了診斷測試在遏制疫情和指導公共衛生應對方面所發揮的關鍵作用。這導致人們專注於快速、準確和具有成本效益的診斷解決方案的開發和實施，促進感染疾病診斷市場的創新，並促進醫療保健專業人員、研發機構和診斷公司之間的合作。

診斷程序的複雜性

診斷程序的複雜性是感染疾病診斷市場成長的主要障礙。這些複雜性包括許多方面，例如測試方法所涉及的技術複雜性、獲得結果所需的時間長度以及需要熟練的人員準確地執行和解釋測試。然而，傳染源的多樣性及其不斷演變的性質進一步使診斷通訊協定變得複雜，並且需要不斷更新和調整檢測技術。這種複雜性不僅增加了醫療保健系統的成本負擔，而且阻礙了感染疾病的及時有效的診斷和治療。

COVID-19 的影響：

COVID-19 大流行對感染疾病診斷市場產生了重大影響。對檢測病毒的診斷測試的需求前所未有地激增，導致市場迅速擴張。這次大流行凸顯了診斷測試在控制感染疾病的重要性，並導致對新診斷技術研發的投資增加。然而，疫情擾亂了供應鏈和分銷網路，導致檢測套組和試劑暫時短缺。

預計在預測期內，真菌感染疾病領域將是最大的。

由於侵襲性真菌疾病的流行，尤其是在免疫力缺乏中，真菌感染疾病預計將在預測期內成為感染疾病診斷市場中最大的部分。意識的提高、診斷技術的進步以及及時準確識別真菌病原體的需求正在推動市場成長。醫院感染發生率的增加、與真菌感染相關的高發病率和死亡率進一步促進了這一領域的擴大。

次世代定序領域預計在預測期內將經歷最高的複合年成長率

由於次世代定序能夠快速、全面地分析病原體的遺傳物質，預計該領域將在預測期內實現最高的複合年成長率。該技術允許在一次測試中同時檢測和表徵多種感染原，包括細菌、病毒、真菌和寄生蟲。透過對病原體的整個基因組或特定區域進行定序，NGS 可以提供對其遺傳多樣性、抗藥性特徵和流行病學模式的寶貴見解。這種綜合方法提高了感染疾病診斷的準確性和效率，特別是當傳統方法可能無法識別致病微生物或區分密切相關的菌株時。此外，NGS有助於即時檢測新興感染疾病和監測疫情，使醫療保健專業人員能夠及時實施有針對性的干涉措施，以更好地管理和控制疾病。

比最大的地區

在整個估計期間，亞太地區佔據了最大的市場佔有率。隨著人口老化，由於免疫力減弱和其他與老齡化相關的因素，他們自然更容易受到感染疾病。這些人口變化增加了對診斷工具和服務的需求，以有效檢測和管理老年人的感染疾病。此外，都市化、生活方式的改變和醫療保健設施的改善等因素也促進了該地區感染疾病診斷市場的擴張。

複合年成長率最高的地區：

預計歐洲地區在預測期內將保持盈利成長。透過歐盟體外診斷法規 (IVDR) 等嚴格的法規結構，當局保證診斷測試的品質、安全性和有效性。這些法規不僅為產品開發和製造設定了高標準，而且有利於創新診斷技術的及時核准和市場准入。此外，遵守這些法規可以增強醫療保健專業人員和患者之間的信任，從而促進先進診斷解決方案的區域採用。

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球感染疾病診斷市場：依產品

  • 測定/試劑
  • 套件
  • 消耗品
  • 裝置
  • 軟體服務

第6章全球感染疾病診斷市場：依疾病分類

  • 細菌感染疾病
  • 病毒感染疾病
  • 黴菌感染疾病
  • 寄生蟲感染疾病
  • 其他感染疾病

第7章全球感染疾病診斷市場：依技術分類

  • 免疫診斷
  • 微生物學
  • 聚合酵素鏈鎖反應
  • 次世代定序
  • 其他技術

第8章全球感染疾病診斷市場：依最終用戶分類

  • 診斷實驗室
  • 學術研究所
  • 醫院
  • 其他最終用戶

第9章全球感染疾病診斷市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Bio-Rad Laboratories, Inc
  • Hologic, Inc
  • Luminex Corporation
  • Abbott Laboratories
  • GenMark Diagnostics, Inc
  • PerkinElmer, Inc
  • Thermo Fisher Scientific Inc
  • Bruker Corporation
  • Sysmex Corporation
  • Nanosphere Health Sciences Inc
  • Trinity Biotech plc
  • InBios International, Inc
  • Meridian Bioscience, Inc
Product Code: SMRC26354

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $23.63 billion in 2024 and is expected to reach $42.78 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Infectious disease diagnostics refers to the process of identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a person's body to diagnose infectious diseases. These diagnostics involve various techniques and methods aimed at detecting specific pathogens or their markers, often through analyzing bodily fluids, tissues, or other samples. Rapid diagnostic tests (RDTs) are also utilized for quick identification in settings with limited resources. Accurate and timely diagnosis of infectious diseases is crucial for effective patient management, initiation of appropriate treatment, implementation of infection control measures, and disease surveillance.

According to the Centers for Disease Control and Prevention (CDC), in 2018, it was reported that approximately 1.7 million infections and 99,000 associated deaths occur every year in American hospitals. According to the U.S. Food and Drug Administration (FDA), in 2020, it was reported that around 300,000 individuals aged 50 and above are diagnosed with pneumococcal pneumonia, every year.

Market Dynamics:

Driver:

Growing demand for point-of-care testing

Point-of-care testing offers rapid, convenient, and decentralized testing solutions, allowing for quick diagnosis and timely treatment decisions at the patient's bedside or in community settings. This shift towards POCT is driven by several factors, including the need for faster turnaround times, especially in infectious disease outbreaks or pandemics like COVID-19. Additionally, POCT reduces the burden on centralized laboratory facilities and healthcare infrastructure, making testing more accessible to underserved populations and remote areas.

Restraint:

High cost of diagnostic tests

The high cost of diagnostic tests poses a significant barrier to the growth of the Infectious Disease Diagnostics Market. These costs encompass various aspects such as test development, manufacturing, and distribution, all of which contribute to the final price borne by patients and healthcare systems. For many individuals, especially in low- and middle-income countries, these expenses are prohibitive, leading to delayed or missed diagnoses and subsequent treatment. However, high costs can strain healthcare budgets, limiting access to essential diagnostic services.

Opportunity:

Rise in public health awareness

The rise in public health awareness has substantially contributed to the growth of the Infectious Disease Diagnostics Market. With an increasing understanding of the importance of early detection and prevention of infectious diseases, individuals and governments alike are investing more resources into diagnostic technologies. The global health crises, such as the COVID-19 pandemic, have highlighted the critical role of diagnostic testing in containing outbreaks and guiding public health responses. Consequently, there is a growing emphasis on the development and adoption of rapid, accurate, and cost-effective diagnostic solutions, driving innovation in the infectious disease diagnostics market and fostering collaborations between healthcare providers, research institutions and diagnostic companies.

Threat:

Complexity of diagnostic procedures

The complexity of diagnostic procedures poses a significant obstacle in the growth of the Infectious Disease Diagnostics Market. These complexities encompass various facets, including the technical intricacies involved in testing methodologies, lengthy turnaround times for obtaining results, and the requirement for skilled personnel to perform and interpret tests accurately. However, the diversity of infectious agents and their evolving nature further complicates diagnostic protocols, necessitating continuous updates and adaptations to detection techniques. These complexities not only increase the cost burden on healthcare systems but also impede timely and effective diagnosis and treatment of infectious diseases.

Covid-19 Impact:

The Covid-19 pandemic significantly impacted the infectious disease diagnostics market. There was an unprecedented surge in demand for diagnostic tests to detect the virus, leading to a rapid expansion of the market. The pandemic highlighted the importance of diagnostic testing in controlling infectious diseases, leading to increased investment in research and development for novel diagnostic technologies. However, the pandemic also disrupted supply chains and distribution networks, causing temporary shortages of testing kits and reagents.

The Fungal Infections segment is expected to be the largest during the forecast period

The fungal infections segment is anticipated to be the largest in the infectious disease diagnostics market during the forecast period due to the rising prevalence of invasive fungal diseases, particularly among immunocompromised individuals. Increased awareness, advancements in diagnostic technologies, and the need for timely and accurate identification of fungal pathogens drive market growth. The growing incidence of hospital-acquired infections and the high morbidity and mortality rates associated with fungal infections further contribute to the segment's expansion.

The Next-generation Sequencing segment is expected to have the highest CAGR during the forecast period

Next-generation Sequencing segment is expected to have the highest CAGR during the forecast period by enabling rapid and comprehensive analysis of pathogens' genetic material. This technology allows for the simultaneous detection and characterization of multiple infectious agents, including bacteria, viruses, fungi, and parasites, in a single test. By sequencing the entire genome or specific regions of pathogens, NGS can provide valuable insights into their genetic diversity, drug resistance profiles, and epidemiological patterns. This comprehensive approach enhances the accuracy and efficiency of infectious disease diagnosis, particularly in cases where traditional methods may fail to identify the causative agent or distinguish between closely related strains. Additionally, NGS facilitates the detection of emerging infectious diseases and the monitoring of outbreaks in real-time, empowering healthcare professionals to implement timely and targeted interventions for better disease management and control.

Region with largest share:

Asia Pacific region commanded the largest share of the market throughout the extrapolated period. As populations age, there's a natural increase in susceptibility to infectious diseases due to weakened immune systems and other age-related factors. This demographic shift creates a higher demand for diagnostic tools and services to effectively detect and manage infectious diseases among the elderly. Additionally, factors such as urbanization, changing lifestyles, and increased access to healthcare facilities further contribute to the expansion of the infectious disease diagnostics market in the region.

Region with highest CAGR:

Europe region is poised to hold profitable growth during the projection period. Through stringent regulatory frameworks, such as the European Union's In Vitro Diagnostic Regulation (IVDR), authorities ensure the quality, safety, and efficacy of diagnostic tests. These regulations not only set high standards for product development and manufacturing but also facilitate timely approvals and market access for innovative diagnostic technologies. Moreover, compliance with these regulations fosters trust among healthcare professionals and patients, thereby driving the regional adoption of advanced diagnostic solutions.

Key players in the market

Some of the key players in Infectious Disease Diagnostics market include Bio-Rad Laboratories, Inc, Hologic, Inc, Luminex Corporation, Abbott Laboratories, GenMark Diagnostics, Inc, PerkinElmer, Inc, Thermo Fisher Scientific Inc, Bruker Corporation, Sysmex Corporation, Nanosphere Health Sciences Inc, Trinity Biotech plc, InBios International, Inc and Meridian Bioscience, Inc.

Key Developments:

In February 2023, Abbott to acquire Cardiovascular Systems for $837.6 mln. The deal will help Abbott gain access to CSI's minimally invasive device to treat blocked arteries.

In May 2022, Quidel Corporation a US-based company that provides rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems, has acquired Ortho Clinical Diagnostics and the succeeding business groups.

Products Covered:

  • Assays & Reagents
  • Kits
  • Consumables
  • Instruments
  • Software & Services

Diseases Covered:

  • Bacterial Infections
  • Viral Infections
  • Fungal Infections
  • Parasitic Infections
  • Other Diseases

Technologies Covered:

  • Immunodiagnostics
  • Microbiology
  • Polymerase Chain Reaction
  • Next-generation Sequencing
  • Other Technologies

End Users Covered:

  • Diagnostic Laboratories
  • Academic Research Institutes
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infectious Disease Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Assays & Reagents
  • 5.3 Kits
  • 5.4 Consumables
  • 5.5 Instruments
  • 5.6 Software & Services

6 Global Infectious Disease Diagnostics Market, By Disease

  • 6.1 Introduction
  • 6.2 Bacterial Infections
  • 6.3 Viral Infections
  • 6.4 Fungal Infections
  • 6.5 Parasitic Infections
  • 6.6 Other Infectious Diseases

7 Global Infectious Disease Diagnostics Market, By Technology

  • 7.1 Introduction
  • 7.2 Immunodiagnostics
  • 7.3 Microbiology
  • 7.4 Polymerase Chain Reaction
  • 7.5 Next-generation Sequencing
  • 7.6 Other Technologies

8 Global Infectious Disease Diagnostics Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Laboratories
  • 8.3 Academic Research Institutes
  • 8.4 Hospitals
  • 8.5 Other End Users

9 Global Infectious Disease Diagnostics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Bio-Rad Laboratories, Inc
  • 11.2 Hologic, Inc
  • 11.3 Luminex Corporation
  • 11.4 Abbott Laboratories
  • 11.5 GenMark Diagnostics, Inc
  • 11.6 PerkinElmer, Inc
  • 11.7 Thermo Fisher Scientific Inc
  • 11.8 Bruker Corporation
  • 11.9 Sysmex Corporation
  • 11.10 Nanosphere Health Sciences Inc
  • 11.11 Trinity Biotech plc
  • 11.12 InBios International, Inc
  • 11.13 Meridian Bioscience, Inc

List of Tables

  • Table 1 Global Infectious Disease Diagnostics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 4 Global Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 5 Global Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 6 Global Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 7 Global Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 8 Global Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 9 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 10 Global Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 11 Global Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 12 Global Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 13 Global Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 14 Global Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 15 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 16 Global Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 17 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 18 Global Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 19 Global Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 20 Global Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 21 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 22 Global Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 23 Global Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 24 Global Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 25 North America Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 26 North America Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 27 North America Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 28 North America Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 29 North America Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 30 North America Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 31 North America Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 32 North America Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 33 North America Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 34 North America Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 35 North America Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 36 North America Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 37 North America Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 38 North America Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 39 North America Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 40 North America Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 41 North America Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 42 North America Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 43 North America Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 44 North America Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 45 North America Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 46 North America Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 47 North America Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 48 North America Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 49 Europe Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 50 Europe Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 51 Europe Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 52 Europe Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 53 Europe Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 54 Europe Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 55 Europe Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 56 Europe Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 57 Europe Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 58 Europe Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 59 Europe Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 60 Europe Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 61 Europe Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 62 Europe Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 63 Europe Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 64 Europe Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 65 Europe Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 66 Europe Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 67 Europe Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 68 Europe Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 69 Europe Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 70 Europe Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 71 Europe Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 72 Europe Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 73 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 74 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 75 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 76 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 77 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 78 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 79 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 80 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 81 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 82 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 83 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 84 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 85 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 86 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 87 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 88 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 89 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 90 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 91 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 92 Asia Pacific Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 93 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 94 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 95 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 96 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 97 South America Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 98 South America Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 99 South America Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 100 South America Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 101 South America Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 102 South America Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 103 South America Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 104 South America Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 105 South America Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 106 South America Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 107 South America Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 108 South America Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 109 South America Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 110 South America Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 111 South America Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 112 South America Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 113 South America Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 114 South America Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 115 South America Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 116 South America Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 117 South America Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 118 South America Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 119 South America Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 120 South America Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 121 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
  • Table 122 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
  • Table 123 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
  • Table 124 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
  • Table 125 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 126 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 127 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
  • Table 128 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
  • Table 129 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
  • Table 130 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
  • Table 131 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
  • Table 132 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
  • Table 133 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
  • Table 134 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 135 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 136 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
  • Table 137 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
  • Table 138 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
  • Table 139 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 140 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 141 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 142 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
  • Table 143 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 144 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)